Post has attachment
Top stories of the year: Digitally #smart drugs, mergers and price-gouging

2015 was a year of considerable change for the global pharmaceutical industry. From smart drugs to mergers and price-gouging, a lot changed in the world of drugs.

The year witnessed a major corporate reshuffle at Google. This led to the creation of Alphabet Inc. – an American multinational conglomerate created as the parent company of Google and several other companies that were previously owned by or tied to Google.
Alphabet now has several technology, #life sciences, investment capital and research companies under its umbrella. For the pharma industry, the creation of Alphabet has signaled the coming together of #drugs and technology.

www.pharmacompass.com

http://bit.ly/1UHC67u
Photo

Post has attachment
#Teva’s third strike at the #Japanese generic market, the new favorite of drug makers

Last fortnight, #Japan dominated the pharmaceutical deal making scenario, giving us the much needed respite from compliance-related news coming from the United States week after week.

In November-end, Israel’s #Teva Pharmaceutical – the world’s largest generic drug maker – established an “unprecedented partnership in Japan” with Japan’s largest pharmaceutical company, #Takeda.

#Teva will have a 51 percent stake in the new company, while #Takeda will have 49 percent.

http://www.pharmacompass.com/pharma-news/teva-s-third-strike-at-the-japanese-generic-market-the-new-favorite-of-drug-makers
Photo
Wait while more posts are being loaded